Experimental study of EGFR-TKI aumolertinib combined with ionizing radiation in EGFR mutated NSCLC brain metastases tumor

Zhang, YS; Li, YP; Han, YH; Li, M; Li, X; Fan, FT; Liu, H; Li, SS

Liu, H; Li, SS (通讯作者)，Bengbu Med Coll, Sch Pharm, Bengbu, Peoples R China.

EUROPEAN JOURNAL OF PHARMACOLOGY, 2023; 945 ():

Abstract

Aumolertinib is an irreversible third-generation epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI), although it has been administe......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索